-- Days : -- HRS : -- MIN : -- SEC
Register Now →

Christopher A. Powers, PharmD

Articles by Christopher A. Powers, PharmD

Placing formulary restrictions on brand name drugs shifts use toward generics, lowers the cost per prescription fill, and has minimal impact on overall adherence for antidiabetes, antihyperlipidemia, and antihypertension medications among low-income subsidy recipients in Medicare Part D plans.